CD44 and neoplasm: The importance of CD44 splicing in tumor progression was clearly demonstrated in a study from the group of Riccardo Fodde, which showed that epithelial-mesenchymal transition (EMT) and the reverse process of mesenchymal-epithelial transition might be regulated by a splicing switch between CD44v6 to CD44s and other proteins, including NUMB2/4.